Pharmacist · Maryland · SOC 29-1051
2026 Pharmacist Pay in Maryland: BLS Median + Real Take-Home
BLS Occupational Employment and Wage Statistics, 2024 reference period · BEA Regional Price Parity 2023 vintage · Last synced 2026-05-05.
TL;DR
- Maryland pays Pharmacists a BLS median of $135,550 — the more useful number is $129,586, what that paycheck buys after rent and services.
- Pharmacist ranking: #33 on the BLS table, #46 once cost of living is in.
- Mid-band cost of living: real and nominal wage are within a few percent of each other.
- Bottom quartile $127,510, top quartile $155,220. The P90 ($167,230) is roughly 1.5× the P10 ($108,680).
Wage breakdown — Maryland
| Percentile | Nominal (BLS) | Real (BEA RPP-adjusted) |
|---|---|---|
| P10 (entry tier) | $108,680 | $103,899 |
| P25 (lower quartile) | $127,510 | $121,900 |
| P50 (median) | $135,550 | $129,586 |
| P75 (upper quartile) | $155,220 | $148,391 |
| P90 (top tier) | $167,230 | $159,873 |
| Mean | $136,210 | $130,217 |
| Employment | 5,850 Pharmacists in Maryland | |
Cost of living — BEA Regional Price Parity
| Component | Maryland index (US = 100) |
|---|---|
| All-items RPP | 104.6 |
| Goods | 103.2 |
| Services | 108.7 |
| Rents | 119.9 |
Maryland's overall RPP (104.6) is close to the national 100 baseline; nominal and real wage move roughly together.
After-tax take-home — Maryland (2024 BLS · 2024 tax year, single filer)
Layer-by-layer take-home math at the BLS median
| Layer | Amount | Note |
|---|---|---|
| Gross BLS P50 (Pharmacist) | $135,550 | nominal median |
| Federal income tax | −$21,350 | 15.8% effective; std deduction $15,750 applied |
| State income tax | −$6,368 | 2–5.75% (graduated, +county piggyback 2.25–3.2%) |
| FICA (SS 6.2% + Medicare 1.45%) | −$10,370 | SS capped at $183,600 wage base |
| Take-home (after-tax) | $97,463 | 71.9% of gross |
| Real take-home (RPP-adjusted) | $93,175 | ÷ (104.6 / 100) BEA cost-of-living |
What the Maryland state-tax burden means for Pharmacist take-home
Mid-band state-tax burden at 4.7% effective. Combined with federal and FICA, take-home is $97,463 (71.9% of gross). After the 104.6 RPP, real take-home is $93,175. Local-tax overlay: Maryland counties piggyback 2.25–3.2% on state liability — Baltimore City and Howard / Montgomery / PG counties at the top of the range.
Computed from 2026 IRS federal brackets (Rev. Proc. 2025-32), 2026 state DOR brackets, and 2026 FICA rates. Single filer, standard deduction, no other adjustments. See methodology · tax for limitations (married filers, ITM/SALT itemizers, retirement deferrals, HSA, dependent credits, etc.).
National context
Across the United States, BLS reports a national median of $137,480 for Pharmacists with mean pay of $137,210 and total employment of 328,870. Maryland sits at #33 on nominal pay and #46 on real (cost-adjusted) pay among the 51 states and DC. After cost adjustment, Maryland falls 13 positions — the cost premium eats into the headline wage.
Frequently asked questions
- How many Pharmacists does Maryland employ?
- BLS OES counts 5,850 Pharmacists employed in Maryland in the most recent release. Employment density relative to population determines whether wage tiers reflect a robust competitive market or a thinner labor pool.
- Where does Maryland rank for Pharmacist pay?
- On nominal BLS wages alone, Maryland ranks among the 51 states and DC by median pay. After the BEA cost-of-living adjustment the ordering changes — high-cost states fall, low-cost states rise. Both rankings are shown in the data table on this page.
- How wide is the wage spread in Maryland?
- P10 to P90 spans $108,680 to $167,230. That spread captures entry-level to top-quartile pay, including specialty differentials and metro-area variance within the state.
- Should I negotiate based on the BLS median for Maryland?
- The BLS median is a calibration anchor, not a ceiling. Use it to validate that an offer is in-band — anything well below the P25 in this state is a flag, anything above the P75 typically requires demonstrable specialty depth, niche credentials, or a high-COL metro within Maryland.
- When does this data update?
- BLS OES releases a new May reference set roughly each spring; we re-run the ETL pipeline within two weeks of release. BEA RPP refreshes annually. The last-synced timestamp at the top of this page reflects the most recent build.
- PharmD ROI in Maryland — does the salary justify $150-220K of tuition?
- PharmD programs in Maryland typically run $35-60K/year tuition × 4 years plus 4 years of foregone earnings, putting the all-in cost over $200K for many students. With a Maryland pharmacist median in the BLS table above and retail pay compression in 2023-2025, ROI breakeven is now 12-18 years post-graduation in most markets — substantially worse than a decade ago. Hospital and industry tracks payback faster; retail-only careers have a much weaker ROI than the historical baseline.
- Is the pharmacist labor market oversupplied in Maryland?
- Maryland pharmacist labor markets vary. National PharmD graduate output peaked around 2018 and has stayed above retiree replacement rates, contributing to chain-pharmacy hour cuts and offers below historical BLS norms in saturated metros. Rural Maryland markets remain undersupplied — sign-on bonuses of $20-50K for rural retail or hospital roles are common. Hospital and clinical roles requiring PGY-1/PGY-2 residency are not oversupplied; specialty boards (BCPS, BCOP, BCACP) are still differentiators that push pay above the BLS median.
Sources & methodology
- U.S. Bureau of Labor Statistics — Occupational Employment and Wage Statistics (OES), SOC 29-1051, 2024 reference period.
- U.S. Bureau of Economic Analysis — Regional Price Parities, 2023 vintage (all-items, goods, services, rents).
- Real-wage figures = nominal BLS wage ÷ (state RPP / 100).
- See the methodology page for full computation details and limitations.
Cross-comparison: see how Maryland Pharmacist pay ranks against the other 254 state × occupation pages on the Real Wage Atlas → — four-way ranking by real wage, after-tax take-home, state-tax savings, and cost-of-living arbitrage.